CO-DIOVAN 8012.5 MG FILM COATED TABLETS Israel - English - Ministry of Health

co-diovan 8012.5 mg film coated tablets

novartis israel ltd - hydrochlorothiazide; valsartan - film coated tablets - valsartan 80 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension for patients in whom combination therapy is appropriate.

CO-DIOVAN 16012.5 MG FILM-COATED TABLETS Israel - English - Ministry of Health

co-diovan 16012.5 mg film-coated tablets

novartis israel ltd - hydrochlorothiazide; valsartan - film coated tablets - valsartan 160 mg; hydrochlorothiazide 12.5 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

CO-DIOVAN 16025 MG FILM-COATED TABLETS Israel - English - Ministry of Health

co-diovan 16025 mg film-coated tablets

novartis israel ltd - hydrochlorothiazide; valsartan - film coated tablets - valsartan 160 mg; hydrochlorothiazide 25 mg - valsartan and diuretics - valsartan and diuretics - co-diovan is indicated for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

PROLEUKIN Israel - English - Ministry of Health

proleukin

megapharm ltd - aldesleukin - powder for solution for infusion - aldesleukin 18 miu - aldesleukin - proleukin (aldesleukin) is indicated for the treatment of adults with metastatic renal cell carcinoma (metastatic rcc). proleukin is indicated for the treatment of adults with metastatic melanoma.careful patient selection is mandatory prior to the administration of proleukin.

VECTOR PLUS 16012.5 Israel - English - Ministry of Health

vector plus 16012.5

unipharm ltd, israel - hydrochlorothiazide; valsartan - tablets - valsartan 160 mg; hydrochlorothiazide 12.5 mg - valsartan - for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

VECTOR PLUS 16025 Israel - English - Ministry of Health

vector plus 16025

unipharm ltd, israel - hydrochlorothiazide; valsartan - film coated tablets - valsartan 160 mg; hydrochlorothiazide 25 mg - valsartan - for the treatment of hypertension in patients whose blood pressure is not adequately controlled by monotherapy. this fixed combination should be used as second-line therapy.

VECTOR PLUS 8012.5 Israel - English - Ministry of Health

vector plus 8012.5

unipharm ltd, israel - hydrochlorothiazide; valsartan - film coated tablets - valsartan 80 mg; hydrochlorothiazide 12.5 mg - valsartan - for the treatment of hypertension for patients in whom combination therapy is appropriate.

MIRCERA 360 MCG0.6 ML Israel - English - Ministry of Health

mircera 360 mcg0.6 ml

roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta - solution for injection - methoxy polyethylene glycol-epoetin beta 360 mcg / 0.6 ml - erythropoietin - erythropoietin - treatment of anemia associated with chronic kidney disease (ckd).

MIRCERA 50 MCG0.3 ML Israel - English - Ministry of Health

mircera 50 mcg0.3 ml

roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta - solution for injection - methoxy polyethylene glycol-epoetin beta 50 mcg / 0.3 ml - methoxy polyethylene glycol-epoetin beta - methoxy polyethylene glycol-epoetin beta - treatment of anemia associated with chronic kidney disease (ckd).

MIRCERA 75 MCG0.3 ML Israel - English - Ministry of Health

mircera 75 mcg0.3 ml

roche pharmaceuticals (israel) ltd - methoxy polyethylene glycol-epoetin beta - solution for injection - methoxy polyethylene glycol-epoetin beta 75 mcg / 0.3 ml - methoxy polyethylene glycol-epoetin beta - methoxy polyethylene glycol-epoetin beta - treatment of anemia associated with chronic kidney disease (ckd).